🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, prospective, single-arm, phase 2 clinical trial desi...
Status
Recruiting
Location
Anhui Provincial Cancer Hospital
Start Date
2024-09-12
Trial ID
NCT06288360
Treatments Being Tested
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This is a Multi-center, Open-label, Randomized Controlled,phase 2 clinical ...
Status
Terminated
Location
Tongji hospital of Tongji Medical College, Huazhong University of Science and Technology
Start Date
2020-04-03
Trial ID
NCT04294784
Treatments Being Tested
This review will evaluate the efficacy and safety of SHR1210 (Camrelizumab)...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2023-06-01
Trial ID
NCT05862064
Treatments Being Tested
This phase II study evaluates the efficacy and safety of neoadjuvant chemoi...
Status
Not Yet Recruiting
Location
P.A. Hertsen Moscow Oncology Research Institute
Start Date
2026-02
Trial ID
NCT07400094
Treatments Being Tested
Patients with previously untreated advanced or metastatic esophageal squamo...
Status
Unknown
Location
Jing Huang
Start Date
2018-07-31
Trial ID
NCT03603756
Treatments Being Tested
In this single-arm study, pathologically confirmed advanced head and neck s...
Status
Unknown
Location
Hunan cancer Hospital
Start Date
2021-01-20
Trial ID
NCT04922450
Treatments Being Tested
This is a Phase Ib/II, open-label, multi-center umbrella study evaluating t...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2018-10-18
Trial ID
NCT03805399
Treatments Being Tested
To evaluate the efficacy and safety of camrelizumab combined with albumin p...
Status
Unknown
Location
Wenxiang Wang
Start Date
2021-03-01
Trial ID
NCT04767295
Treatments Being Tested